NCT00719121View on ClinicalTrials.gov

Study on Anti-inflammatory Effects of Topical R115866 Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Cutaneous Inflammation
Interventions
DRUG

Talarozole

Topical Application (20 mg)

DRUG

Differin™, 0.1% adapalene gel

Topical Application (20 mg)

Trial Locations (1)

B-4000

Department of DermatopathologyCentre Hospitalier Universitaire du Sart Tilman, Liège

All Listed Sponsors
lead

Stiefel, a GSK Company

INDUSTRY

NCT00719121 - Study on Anti-inflammatory Effects of Topical R115866 Gel | Biotech Hunter | Biotech Hunter